Clinical trial

Progression of Disease in Patients Newly Diagnosed With Glaucoma and Glaucoma Suspects Participating in the GATE Study

NCT03394521

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Routine clinical practice Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Progression of Disease in Patients Newly Diagnosed With Glaucoma and Glaucoma Suspects Participating in the GATE Study

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2015-10-01

PhaseN/A

Conditions

Glaucomaverified · MONDO: glaucoma

Interventions

Routine clinical practiceOTHER

Sponsors & collaborators

University of Aberdeenlead sponsor

Queen's University, Belfastcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03394521 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.